The Lancet Neurology: November 16, 2010

FromThe Lancet Neurology in conversation with

Start listening View podcast show

The Lancet Neurology: November 16, 2010

FromThe Lancet Neurology in conversation with

ratings:

Length:

8 minutes

Released:

Nov 16, 2010

Format:

Podcast episode

Description

Discussion of the RE-LY trial subgroup for the secondary prevention of stroke, and phase 2 results of gene therapy for Parkinson's disease.

Released:

Nov 16, 2010

Format:

Podcast episode

Titles in the series (100)

Our Editors and and the journal’s authors explore their research and its impact on people’s health, health care, and health policy in this regular podcast.

Skip carousel

The Lancet Neurology: January 22, 2008 by The Lancet Neurology in conversation with
5 min listen
The Lancet Neurology: February 18, 2010 by The Lancet Neurology in conversation with
11 min listen
The Lancet Neurology: May 19, 2008 by The Lancet Neurology in conversation with
7 min listen
The Lancet Neurology: September 15, 2008 by The Lancet Neurology in conversation with
7 min listen
The Lancet Neurology: December 17, 2007 by The Lancet Neurology in conversation with
7 min listen
The Lancet Neurology: December 14, 2009 by The Lancet Neurology in conversation with
13 min listen
The Lancet Neurology: June 15, 2009 by The Lancet Neurology in conversation with
6 min listen
The Lancet Neurology: June 16, 2008 by The Lancet Neurology in conversation with
16 min listen
The Lancet Neurology: October 13, 2008 by The Lancet Neurology in conversation with
8 min listen
The Lancet Neurology: February 18, 2008 by The Lancet Neurology in conversation with
5 min listen
The Lancet Neurology: July 18, 2011 by The Lancet Neurology in conversation with
10 min listen
The Lancet Neurology: May 19, 2010 by The Lancet Neurology in conversation with
9 min listen
The Lancet Neurology: July 14, 2008 by The Lancet Neurology in conversation with
8 min listen
The Lancet Neurology: March 14, 2008 by The Lancet Neurology in conversation with
5 min listen
The Lancet Neurology: September 08, 2009 by The Lancet Neurology in conversation with
7 min listen
The Lancet Neurology: May 12, 2009 by The Lancet Neurology in conversation with
10 min listen
The Lancet Neurology: March 16, 2009 by The Lancet Neurology in conversation with
9 min listen
The Lancet Neurology: November 10, 2008 by The Lancet Neurology in conversation with
6 min listen
The Lancet Neurology: April 15, 2009 by The Lancet Neurology in conversation with
7 min listen
The Lancet Neurology: December 08, 2008 by The Lancet Neurology in conversation with
9 min listen
The Lancet Neurology: August 11, 2008 by The Lancet Neurology in conversation with
8 min listen
The Lancet Neurology: April 18, 2008 by The Lancet Neurology in conversation with
8 min listen
The Lancet Neurology: August 16, 2010 by The Lancet Neurology in conversation with
8 min listen
The Lancet Neurology: January 19, 2009 by The Lancet Neurology in conversation with
10 min listen
The Lancet Neurology: September 20, 2010 by The Lancet Neurology in conversation with
10 min listen
The Lancet Neurology: April 21, 2010 by The Lancet Neurology in conversation with
12 min listen
The Lancet Neurology: August 13, 2012 by The Lancet Neurology in conversation with
19 min listen
The Lancet Neurology: February 16, 2009 by The Lancet Neurology in conversation with
8 min listen
The Lancet Neurology: October 12, 2009 by The Lancet Neurology in conversation with
8 min listen
The Lancet Neurology: August 19, 2009 by The Lancet Neurology in conversation with
10 min listen

More Episodes from The Lancet Neurology in conversation with

Skip carousel

Jacqueline French and Jacob Pellinen on the diagnosis of epilepsy by The Lancet Neurology in conversation with
23 min listen
Jaimie Steinmetz, Theo Vos, Katrin Seeher and Tarun Dua on the global burden of disorders affecting the nervous system by The Lancet Neurology in conversation with
25 min listen
Giovanni Frisoni on biomarker-based diagnosis of neurocognitive disorders by The Lancet Neurology in conversation with
12 min listen
Marianne Chapleau and Gil Rabinovici on posterior cortical atrophy by The Lancet Neurology in conversation with
22 min listen
Cecilia Åkerlund and David Nelson on prognosis of traumatic brain injury by The Lancet Neurology in conversation with
18 min listen
Rustam Al-Shahi Salman on the effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage by The Lancet Neurology in conversation with
24 min listen
Njideka Okubadejo and Mie Rizig on Parkinson's disease in African and African admixed populations by The Lancet Neurology in conversation with
27 min listen
Anthony Feinstein on a trial of cognitive rehabilitation and exercise in people with progressive multiple sclerosis by The Lancet Neurology in conversation with
15 min listen
William Jagust on amyloid β and cognition by The Lancet Neurology in conversation with
14 min listen
Stephen Strittmatter on a first-in-human trial for treating chronic cervical spinal cord injury by The Lancet Neurology in conversation with
15 min listen
Benzi Kluger, Claire Creutzfeldt, and Malenna Sumrall on palliative care for individuals with neurological diseases by The Lancet Neurology in conversation with
17 min listen
Andrew Cole on the complexities underlying epilepsy in people with glioblastoma by The Lancet Neurology in conversation with
19 min listen
Karen Duff and Connor Langworth-Green on tauopathies and chronic inflammation by The Lancet Neurology in conversation with
15 min listen
Kerstin Hellwig on family planning considerations in MS by The Lancet Neurology in conversation with
14 min listen
Geraldine Dawson on advances and in the prediction of autism during infancy by The Lancet Neurology in conversation with
25 min listen
Ellisiv Mathiesen on tenecteplase for patients with wake-up stroke by The Lancet Neurology in conversation with
9 min listen
Beau Ances on amyloid biomarkers in Alzheimer’s by The Lancet Neurology in conversation with
12 min listen
Axel Petzold on the diagnosis and classification of optic neuritis by The Lancet Neurology in conversation with
20 min listen
Maeike Zijlmans on using biomarkers to tailor epilepsy surgery by The Lancet Neurology in conversation with
15 min listen
Jerome Siegel on sleep habits by The Lancet Neurology in conversation with
44 min listen
Laurent Servais and Dora Markati on emerging therapies for Duchenne muscular dystrophy by The Lancet Neurology in conversation with
17 min listen
Andreas Charidimou on new criteria for diagnosis of cerebral amyloid angiopathy by The Lancet Neurology in conversation with
23 min listen
Sarah Tabrizi and Cristina Sampaio on classifying Huntington's and new therapies by The Lancet Neurology in conversation with
19 min listen
Mark Hallett on functional neurological disorder by The Lancet Neurology in conversation with
9 min listen
Eva Feldman on advances in understanding ALS by The Lancet Neurology in conversation with
23 min listen
Estrella Morenas-Rodriguez and Christian Haass on soluble TREM2 and Alzheimer's by The Lancet Neurology in conversation with
27 min listen
John Collinge on a treatment for CJD by The Lancet Neurology in conversation with
15 min listen
Alexandra Durr on riluzole in patients with spinocerebellar ataxia type 2 by The Lancet Neurology in conversation with
8 min listen
Giuseppe Citerio on frailty and TBI by The Lancet Neurology in conversation with
10 min listen
Alberto Costa on memantine in adolescents and young adults with Down syndrome by The Lancet Neurology in conversation with
15 min listen

Related podcast episodes

Skip carousel

Ataxin-2 polyglutamine expansions aberrantly sequester TDP-43, drive ribonucleoprotein condensate transport dysfunction and suppress local translation by PaperPlayer biorxiv cell biology
20 min listen
RAB3 phosphorylation by pathogenic LRRK2 impairs trafficking of synaptic vesicle precursors by PaperPlayer biorxiv cell biology
20 min listen
Parkinson’s-related psychosis with Dr. Alberto J. Espay: Alberto J. Espay, MD, MSc, conducts a Masterclass lecture on treating patients with Parkinson’s-related psychosis from the in Cincinnati. The meeting was sponsored by and . is professor of neurology at the University of Cincinnati. He also serves... by Psychcast
22 min listen
EP 69: Chief Scientific Officer at Parkinson's Foundation, Dr James Beck, and Dr Ignacio Mata, Professor at the Cleveland Clinic, on the genetics of Parkinson’s disease and the future of precision treatments: What is the role of genetics in Parkinson’s disease? by The Genetics Podcast
41 min listen
Episode 69:DUPLEX Sparsentan, it’s no Acthar Gel: A real multicenter RCT for the treatment of FSGS by Freely Filtered, a NephJC Podcast
102 min listen
LRRK2 Suppresses Lysosome Degradative Activity in Macrophages and Microglia via Transcription Factor E3 Inhibition by PaperPlayer biorxiv cell biology
20 min listen

Discover this podcast and so much more

The Lancet Neurology: November 16, 2010

The Lancet Neurology: November 16, 2010

Description

Titles in the series (100)

More Episodes from The Lancet Neurology in conversation with

Related podcast episodes